![]() |
市場調查報告書
商品編碼
2024561
骨移植材料及替代品市場報告:按材料類型、應用、最終用戶和地區分類(2026-2034 年)Bone Graft and Substitutes Market Report by Material Type, Application, End User, and Region 2026-2034 |
||||||
2025年,全球骨移植和骨替代材料市場規模達35億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到55億美元,2026年至2034年的複合年成長率(CAGR)為4.83%。推動該市場強勁成長的因素包括:骨骼相關疾病發生率上升、移植材料技術的快速進步、整形外科手術數量的增加、微創手術技術的日益普及以及政府對研發的支持。
骨骼和關節疾病發生率增加
骨質疏鬆症、骨關節炎和脊椎疾病等骨骼和關節疾病的日益普遍是市場成長的主要驅動力。這導致對有效治療方法的需求增加,包括脊椎融合手術、關節重組和創傷手術中必不可少的骨移植和替代材料,進一步推動了市場成長。此外,全球老年人口的不斷成長,尤其是易患關節疾病的老年人口,也促進了市場成長。同時,體力活動減少和營養不良等生活方式因素也增加了骨骼和關節疾病的發生率,從而促進了市場成長。人們對各種疾病的認知不斷提高,診斷率不斷提高,也推動了對骨移植和替代材料的需求增加,進一步促進了市場成長。
科技的快速發展
用於骨移植的生物材料的進步是市場成長的主要驅動力。因此,合成和生物相容性材料的開發,例如磷酸鈣陶瓷、生物活性玻璃和各種能夠有效促進骨再生和癒合的聚合物,正在加速市場成長。這些材料具有諸多優勢,包括降低感染疾病傳播風險、品質穩定以及能夠根據特定臨床需求定製材料性能。此外,3D列印等先進技術的廣泛應用,能夠製造與患者解剖結構完美匹配的客製化移植物,從而改善手術效果,預計也將推動市場成長。同時,奈米技術在骨移植材料中的快速應用,能夠更真實地模擬天然骨結構,並提高骨誘導性和生物相容性,也促進了市場成長。
整形外科手術數量增加
全球整形外科手術數量的不斷成長,主要受運動傷害和意外事故增加以及人口老化的影響,是推動市場成長的主要因素。此外,骨移植和替代材料在脊椎融合手術、保肢手術和重組手術等手術中的應用日益廣泛,也為市場成長提供了積極的前景。同時,糖尿病和類風濕性關節炎等影響肌肉骨骼系統的慢性疾病盛行率的上升,也導致整形外科手術數量增加,進一步促進了市場成長。此外,整形外科手術的多樣化,包括新手術技術的出現和手術適應症的擴大,也為市場成長做出了貢獻。
人們越來越傾向選擇微創手術
由於微創手術 (MIS) 具有許多優勢,例如減輕患者的身體負擔、縮短住院時間和恢復期,因此患者和外科醫生越來越傾向於選擇微創手術,這推動了市場成長。此外,適用於微創手術的骨移植產品的研發和應用,帶動了對同種異體骨移植、去礦骨基質和合成骨移植的需求,也顯著促進了市場成長。同時,手術器械和影像技術的快速發展,使得手術更加精準高效,也推動了市場成長。因此,開發與骨移植材料相容的專用微創手術器械,以提高手術效率和成功率,也促進了市場成長。
政府支持措施的實施
政府機構和醫療機構對骨移植材料及其替代品研發的大力支持是推動市場成長的主要動力。這包括資金投入、津貼以及簡化新產品和先進產品的監管核准,從而支持創新骨移植解決方案的開發。此外,研究機構與產業相關人員之間合作的加強,促進了技術創新和臨床療效的提升,也推動了市場成長。同時,官民合作關係的興起,為檢驗新產品的有效性和安全性提供了臨床試驗和研究平台,也促進了市場成長。此外,簡化新產品核准流程的政策訂定,顯著降低了新產品研發的時間和成本,也為市場成長做出了貢獻。
The global bone graft and substitutes market size reached USD 3.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.83% during 2026-2034. The market is experiencing robust growth, driven by the rising incidence of bone-related disorders, rapid technological advancements in graft materials, increasing incidences of orthopedic surgeries, growing preference for minimally invasive (MI) surgical techniques, and the implementation of supportive governmental initiatives in research and development (R&D).
Increasing incidence of bone and joint disorders
The rising prevalence of bone and joint disorders, such as osteoporosis, osteoarthritis, and spinal disorders, is one of the major factors boosting the market growth. In line with this, the growing demand for effective treatment options, including bone grafts and substitutes, as they are crucial in surgeries related to spinal fusions, joint reconstruction, and trauma surgeries, is favoring the market growth. Moreover, the increasing geriatric population across the globe, who are susceptible to joint disorders is propelling the market growth. Along with this, the rising incidence of bone and joint disorders due to lifestyle factors, including reduced physical activity and poor nutrition, is also contributing to the market growth. Besides this, the heightened demand for bone grafts and substitutes due to the growing awareness and diagnosis rates of various conditions is acting as a growth-inducing factor.
Rapid technological advancements
The rising advancements in biomaterials that are used for bone grafting are major factors bolstering the market growth. In line with this, the development of synthetic and biocompatible materials, such as calcium phosphate ceramics, bioactive glasses, and various polymers that efficiently aid in bone regeneration and healing, is providing a thrust to the market growth. They offer several advantages, such as reduced risk of disease transmission, consistent quality, and the ability to tailor the material properties to specific clinical needs. Moreover, the widespread integration of advanced technologies like three-dimensional (3D) printing that enable the creation of customized grafts that perfectly match the patient's anatomy while improving surgical outcomes is anticipated to drive the market growth. Besides this, the rapid utilization of nanotechnology in bone grafting materials to mimic the natural bone structure more closely, offering improved osteoconduction and biocompatibility, is stimulating the market growth.
Increasing cases of orthopedic surgeries
The increasing number of orthopedic surgeries performed across the globe due to the rising prevalence of sports injuries, accidents, and the growing geriatric population, is a major factor propelling the market growth. Moreover, the increasing utilization of bone grafts and substitutes in procedures such as spinal fusion, limb salvage surgeries, and reconstructive surgeries is creating a positive outlook for the market growth. Along with this, the escalation in orthopedic surgeries due to the rising prevalence of chronic diseases that affect the musculoskeletal system, like diabetes and rheumatoid arthritis, is bolstering the market growth. Apart from this, the heightened diversification of orthopedic procedures, including the advent of new surgical techniques and the expansion of surgical indications, are contributing to the market growth.
Growing preference for minimally invasive (MI) surgical procedures
The increasing preference for minimally invasive surgeries (MIS) among patients and surgeons due to its various benefits, such as reduced surgical trauma, shorter hospital stays, and faster recovery times, is acting as a growth-inducing factor. Moreover, the development and adoption of bone grafting products suitable for minimally invasive applications, propelling the demand for allografts, demineralized bone matrices, and synthetic grafts, is providing a considerable boost to the market growth. Additionally, rapid advancements in surgical instruments and imaging technologies, which allow for more precise and efficient surgeries, are acting as a growth-inducing factor. In line with this, the development of specialized MIS tools that are compatible with bone graft materials to enhance the efficiency and success rates of the procedures is fostering the market growth.
Implementation of supportive government initiatives
The increasing support by government bodies and healthcare organizations for research and development (R&D) in bone grafts and substitutes is a major factor fueling the market growth. It includes funding, grants, and facilitation of regulatory approvals for new and advanced products, aiding the development of innovative bone grafting solutions. Moreover, the growing collaboration between research institutions and industry players, leading to technological innovations and improved clinical outcomes, is providing an impetus to the market growth. In line with this, the rising public-private partnerships that provide a platform for clinical trials and studies to validate the efficacy and safety of new products are enhancing the market growth. Apart from this, the imposition of policies that streamline the approval process for new products, significantly reducing the time and cost associated with developing new products, is contributing to the market growth.
Allografts accounts for the majority of the market share
Allografts hold the largest market share as they are extensively used in various orthopedic procedures due to their osteoconductive and osteoinductive properties. They are favored in complex surgeries, such as spinal fusion, due to their ability to mimic natural bone structure and promote new bone growth. Moreover, allografts are available in various forms, including fresh, freeze-dried, and demineralized bone matrices, catering to a wide range of clinical needs. Besides this, the rising preference for allografts due to their effectiveness in facilitating bone healing, thus reducing the risk of patient morbidity associated with autograft harvesting is acting as growth-inducing factors.
Bone graft substitutes comprise synthetic materials or biologically derived products that are used as alternatives to traditional bone grafts. They include ceramics, polymers, and composite materials designed to provide a scaffold for bone growth and reduce the need for autografts or allografts. Moreover, their consistent quality and the elimination of risks related to disease transmission or immune rejection are enhancing the market growth.
Cell-based matrices involve the use of living cells combined with scaffolding materials to promote bone regeneration. They are seeded with a patient's cells or donor cells, making them highly biocompatible and effective in enhancing the bone healing process. Moreover, the widespread integration of stem cell technology and tissue engineering in cell-based matrices is driving the market growth.
Spinal fusion holds the largest share in the industry
Spinal fusion represents the largest segment in the market, driven by the increasing prevalence of spinal disorders, such as degenerative disc disease, scoliosis, and spinal stenosis. Bone grafts and substitutes are essential in spinal fusion surgeries for facilitating the fusion of two or more vertebrae to stabilize the spine and alleviate pain. Moreover, the effectiveness of bone grafts in promoting bone growth and healing is creating a positive outlook for the market growth. Besides this, the increasing utilization of demineralized bone matrices, along with synthetic bone graft substitutes in spinal fusion surgeries, due to their osteoconductive properties and ability to integrate with the patient's bone, is supporting the market growth.
Trauma surgeries involve the use of bone grafts and substitutes in the treatment of fractures and bone defects resulting from accidents, injuries, or surgeries. They help in supporting bone healing, especially in cases of complex fractures or where bone loss has occurred. Moreover, the continuous development of high-strength and biocompatible graft materials that provide structural support and enhance the natural healing process, is fueling the market growth.
Joint reconstruction surgeries, such as hip or knee replacements, often require bone grafts for better integration of implants and restoration of joint function. They help fill bone voids and promote bone ingrowth around prosthetic components to ensure the stability and longevity of the implants. Furthermore, the increasing incidence of joint disorders and the growing geriatric population are contributing to the market growth.
In foot and ankle surgeries, bone grafts are used for reconstructive procedures, treating deformities, and healing of fractures. Moreover, the growing demand for specific types of grafts that can conform to the complex anatomy of the foot and ankle, providing structural support and promoting bone regeneration, is boosting the market growth. Besides this, the rising number of sports-related injuries and conditions like arthritis are favoring the market growth.
Dental bone grafting utilizes grafts to augment the jawbone and support dental implants, especially in cases of bone loss due to periodontal disease or tooth extraction. Along with this, the growing utilization of dental bone grafts owing to the increasing popularity of dental implants for missing teeth is stimulating the market growth. Besides this, rapid advancements in graft materials that ensure better integration and stability of the implants are enhancing the market growth.
Craniomaxillofacial involves the application of bone grafts in surgeries related to the skull, face, and jaws. They are essential in reconstructive surgeries, trauma recovery, and congenital disability repairs. Moreover, the development of customized graft solutions that can adapt to the complex geometries of facial bones, ensuring functional and aesthetic outcomes, is propelling the market growth.
Hospitals represents the leading market segment
Hospitals represent the largest segment due to their comprehensive healthcare services, including advanced surgical procedures that require bone grafts and substitutes. Moreover, they are equipped with advanced facilities and a wide range of medical specialties, making them the preferred choice for complex surgeries, such as spinal fusion, joint reconstruction, and trauma-related procedures. Besides this, the widespread availability of skilled surgeons, multidisciplinary teams, and advanced post-operative care in hospitals is contributing to the market growth. Additionally, hospitals have the infrastructure to support the storage and handling of various types of bone grafts, including those that require specific storage conditions.
Surgical centres are known for procedures that require bone grafting but do not necessitate the extensive resources of a hospital. They include certain types of dental bone grafting, minor joint repairs, and some cosmetic and reconstructive surgeries. Moreover, the heightened focus on minimally invasive (MI) techniques, which reduce patient recovery time and resource utilization, is boosting the market growth.
Clinics include specialized orthopedic and dental clinics that cater to specific procedures that involve bone grafting, such as dental implant placement or minor orthopedic corrections. They provide targeted and specialized care in a more personalized and accessible setting. Additionally, the rising growth in specialized clinics, along with advancements in outpatient surgical techniques, is bolstering the market growth.
North America leads the market, accounting for the largest bone graft and substitutes market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America holds the largest market share, due to the high prevalence of bone-related disorders, advanced healthcare infrastructure, and the presence of key market players in the region. In line with this, the increasing number of orthopedic procedures, including spinal fusion and joint reconstruction surgeries, driving the demand for bone grafts and substitutes, is boosting the market growth. Additionally, the rising medical research and innovation, with substantial investments in developing advanced graft materials and surgical techniques, is fueling the market growth. Along with this, the increasing healthcare expenditure and the presence of well-established healthcare systems is contributing to the market growth.
The Europe's market for bone graft and substitutes is driven by factors, such as the growing geriatric population, increasing incidences of osteoporosis and other bone-related conditions, and the adoption of advanced medical technologies. Along with this, the well-developed healthcare system and the presence of some of the leading players in the medical device industry, is fueling the market growth.
The Asia Pacific region is experiencing rapid growth in the market, attributed to the increasing healthcare expenditure, growing awareness of advanced medical treatments, and an expanding geriatric population. Moreover, the rising number of orthopedic procedures due to the growing middle class and improvements in healthcare infrastructure, is also acting as growth-inducing factors.
In Latin America, the market for bone graft and substitutes is growing steadily, driven by the gradual improvement in healthcare infrastructure and increasing accessibility to advanced medical treatments. Besides this, the increasing prevalence of chronic diseases that affect bone health, coupled with a growing focus on healthcare modernization, is strengthening the market growth.
The market in the Middle East and Africa is evolving due to the improving healthcare infrastructure and increasing government initiatives to modernize healthcare services. Along with this, the widespread adoption of advanced medical technologies, including bone grafts and substitutes, in the region is creating a positive outlook for the market growth.
The major players are engaged in various strategic initiatives to strengthen their market position and respond to the evolving medical needs in orthopedics. They are investing in research and development (R&D) to innovate and improve their product offerings by focusing on developing advanced materials that are more biocompatible, osteoconductive, and osteoinductive. Besides this, the leading firms are emphasizing creating synthetic and hybrid grafts that combine the benefits of natural bone tissue with the versatility and safety of synthetic materials. Moreover, they are expanding their reach through mergers and acquisitions, partnerships with healthcare providers, and collaborations with research institutions to enhance their technological capabilities and market access.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Frequently Asked Questions About the Bone Graft and Substitutes Market Report
1.How big is the global bone graft and substitutes market?
2.What is the expected growth rate of the global bone graft and substitutes market during 2026-2034?
3.What are the key factors driving the global bone graft and substitutes market?
4.What has been the impact of COVID-19 on the global bone graft and substitutes market?
5.What is the breakup of the global bone graft and substitutes market based on the material type?
6.What is the breakup of the global bone graft and substitutes market based on the application?
7.What is the breakup of the global bone graft and substitutes market based on the end user?
8.What are the key regions in the global bone graft and substitutes market?
9.Who are the key players/companies in the global bone graft and substitutes market?